Pharmaceuticals, Biotechnology and Life Sciences
Allergan has made a deal to get Assembly Biosciences’s microbiome gastrointestinal (GI) development programs which will enable Allergane to use more compounds in researching stomach problems.
Allergan has purchased an exclusive option right to acquire Lysosomal Therapeutics (LTI), the company focused on innovative small-molecule research and…
Allergan has won FDA’s approval to sell its breast implants in US.
Ironwood Pharmaceuticals and Allergan have been testing an irritable bowel syndrome with constipation (IBS-C) drug, a formulation of linaclotide colonic…
Allergan has acquired the regenerative medicine company LifeCell for $2.9 billion in cash.
Allergan’s indirect subsidiaries Forest Laboratories, LLS and Forest Pharmaceuticals, Inc. are about to pay $38 million for bad sales and…
Allergan said on Thursday that it was disappointed in the PTAB’s decision to institute IPR proceedings regarding the patents that…
Allergan has announced the availability of TAYTULLATM (norethindrone acetate and ethinyl estradiol capsules and ferrous fumarate capsules)…
Allergan has completed its initial $5 billion in share repurchases under its previously announced share repurchase program…
Allergan has completed the acquisition of Tobira Therapeutics